Hodogaya Chemical Co., Ltd. (JP:4112)
:4112
Top Page
Hodogaya Chemical Co., Ltd.
(4112)
Select Model
Select Model
Rating:66Neutral
Price Target:
¥2,686.00
▲(43.10% Upside)
Action:ReiteratedDate:03/31/26
The score is driven primarily by financial performance: strong balance-sheet flexibility is offset by a recent margin decline and weak, volatile free cash flow. Technicals are a positive tailwind with the price above major moving averages and positive momentum indicators. Valuation is supportive with a moderate P/E and modest dividend yield.
Positive Factors
Conservative Balance Sheet
Low leverage (debt-to-equity ~0.19) gives Hodogaya durable financial flexibility to fund cyclical working capital, selective capex, and R&D without stressing liquidity. This supports stability through chemicals cycle downturns and preserves strategic optionality over months to years.
Negative Factors
Margin Compression
A clear step-down in operating/net margins implies lasting cost pressure, weaker product mix, or pricing erosion. If sustained, lower margins reduce internal cash generation and returns, constraining reinvestment capacity and limiting ability to expand or respond to competitor actions over 2–6 months.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative Balance Sheet
Low leverage (debt-to-equity ~0.19) gives Hodogaya durable financial flexibility to fund cyclical working capital, selective capex, and R&D without stressing liquidity. This supports stability through chemicals cycle downturns and preserves strategic optionality over months to years.
Read all positive factors
Hodogaya Chemical Co., Ltd. (4112) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥37.53B
Dividend Yield2.37%
Average Volume (3M)79.15K
Price to Earnings (P/E)11.8
Beta (1Y)1.24
Revenue Growth-11.70%
EPS Growth-54.82%
CountryJP
Employees922
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)N/A
Shares Outstanding16,827,452
10 Day Avg. Volume72,200
30 Day Avg. Volume79,146
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)0.51
Price to Sales (P/S)0.51
P/FCF Ratio100.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Hodogaya Chemical Co., Ltd. Business Overview & Revenue Model
Company Description
Hodogaya Chemical Co., Ltd. (4112) is a Japan-based company engaged in the development, manufacture, and sale of chemical products. The company operates primarily in sectors such as specialty chemicals, fine chemicals, and synthetic resins. Hodoga...
How the Company Makes Money
null...
Hodogaya Chemical Co., Ltd. Financial Statement Overview
Summary
Income Statement
63
Positive
Balance Sheet
78
Positive
Cash Flow
42
Neutral
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.79B | 48.58B | 44.26B | 43.32B | 41.88B | 41.20B |
| Gross Profit | 17.10B | 18.91B | 16.87B | 16.50B | 17.50B | 15.96B |
| EBITDA | 6.08B | 7.89B | 6.35B | 5.64B | 8.09B | 6.95B |
| Net Income | 2.29B | 3.18B | 2.48B | 2.22B | 3.25B | 3.12B |
Balance Sheet | ||||||
| Total Assets | 87.48B | 79.86B | 81.16B | 72.05B | 66.45B | 62.61B |
| Cash, Cash Equivalents and Short-Term Investments | 11.66B | 10.77B | 12.96B | 10.49B | 11.45B | 9.45B |
| Total Debt | 9.46B | 8.79B | 9.81B | 11.08B | 7.02B | 8.19B |
| Total Liabilities | 23.81B | 21.32B | 23.71B | 22.15B | 18.53B | 18.95B |
| Stockholders Equity | 52.45B | 48.60B | 47.73B | 42.84B | 41.42B | 38.68B |
Cash Flow | ||||||
| Free Cash Flow | 549.00M | 248.00M | 2.99B | -2.06B | 4.38B | 3.07B |
| Operating Cash Flow | 6.12B | 5.67B | 8.34B | 1.06B | 6.14B | 5.38B |
| Investing Cash Flow | -4.51B | -6.55B | -3.95B | -7.04B | -3.57B | -2.69B |
| Financing Cash Flow | -685.00M | -1.88B | -2.07B | 2.29B | -1.85B | -424.00M |
Hodogaya Chemical Co., Ltd. Technical Analysis
Neutral
1877.00
Price Trends
2320.67
Negative
2166.02
Positive
1879.72
Positive
Market Momentum
12.52
Positive
48.09
Neutral
21.95
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4112, the sentiment is Neutral. The current price of 1877 is below the 20-day moving average (MA) of 2334.95, below the 50-day MA of 2320.67, and below the 200-day MA of 1879.72, indicating a neutral trend. The MACD of 12.52 indicates Positive momentum. The RSI at 48.09 is Neutral, neither overbought nor oversold. The STOCH value of 21.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4112.
Hodogaya Chemical Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥36.53B | 9.56 | ― | 1.90% | 2.15% | 16.14% | |
75 Outperform | ¥54.40B | 16.36 | ― | 2.92% | 3.03% | 28.27% | |
74 Outperform | ¥36.94B | 15.61 | ― | 3.70% | 14.83% | 51.42% | |
70 Outperform | ¥58.11B | -468.17 | ― | 4.37% | -1.09% | ― | |
66 Neutral | ¥37.53B | 11.77 | ― | 2.37% | -11.70% | -54.82% | |
66 Neutral | ¥40.70B | 35.78 | ― | 3.24% | 1.83% | -8.54% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
* Basic Materials Sector Average
JP:4112
Hodogaya Chemical Co., Ltd.
2,298.00
946.26
70.00%
JP:4027
Tayca Corporation
1,904.00
766.74
67.42%
JP:4078
Sakai Chemical Industry Co., Ltd.
3,665.00
1,413.67
62.79%
JP:4362
Nippon Fine Chemical Co., Ltd.
2,451.00
562.63
29.79%
JP:4462
Ishihara Chemical Company,Ltd.
2,517.00
628.64
33.29%
JP:4611
Dai Nippon Toryo Company, Limited
1,304.00
234.01
21.87%
Hodogaya Chemical Co., Ltd. Corporate Events
Hodogaya Chemical to Acquire Hungary’s Framochem in Push for Global Specialty Chemicals Growth
Mar 27, 2026
Hodogaya Chemical will acquire 100% of Hungarian firm Framochem Francia-Magyar Finomkemiai Kft, making it a wholly owned subsidiary as part of its new medium-term management plan to expand its Specialty Chemicals business. Framochem, founded in 19...
Hodogaya Chemical Buys Stake in YUKI GOSEI KOGYO to Drive Nucleic Acid CDMO Push
Feb 26, 2026
Hodogaya Chemical has agreed to collaborate with YUKI GOSEI KOGYO in the nucleic acid therapeutics contract development and manufacturing business, combining Hodogaya’s non-GMP oligonucleotide capabilities with YGK’s GMP-compliant manu...
Hodogaya Chemical Expands Employee Stock Ownership Plan to Entire Group
Feb 24, 2026
Hodogaya Chemical Co., Ltd. will extend its Japanese Employee Stock Ownership Plan to all employees of the company and its domestic consolidated subsidiaries from fiscal 2026, broadening an incentive scheme first introduced in 2023 and partially e...
Hodogaya Chemical Unveils FY2025 Third-Quarter Consolidated Results Overview
Feb 13, 2026
Hodogaya Chemical Co., Ltd. released its consolidated financial results presentation for the third quarter of fiscal year 2025, which ends in March 2026. The materials outline an overview of group performance, segment-by-segment results, and refer...
Hodogaya Chemical Profit Slumps as Company Sticks to Weaker Full-Year Outlook
Feb 13, 2026
Hodogaya Chemical reported consolidated net sales of ¥34.45 billion for the nine months to December 31, 2025, down 7.5% year on year, with operating profit plunging 47.1% to ¥2.43 billion and profit attributable to owners of parent falli...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.